Special Interview with Prof. Georgios Germanidis from Aristotle University of Thessaloniki
The Editorial Office of Hepatoma Research was honored and excited to have a special interview with Prof. Georgios Germanidis from the First Department of Internal Medicine at AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece, on June 7, 2024. In the interview, Prof. Germanidis highlighted the main findings and the significance of his team’s newly published article titled "Shedding light on the role of LAG-3 in hepatocellular carcinoma: unraveling immunomodulatory pathways". Additionally, he outlined further research on HCC treatments and shared insights from his professional experience in this field. Finally, Prof. Germanidis provided valuable suggestions for our journal’s future development.
Introduction to the Interviewee
Prof. Georgios Germanidis is a Full professor of gastroenterology and serves as the Head of the Hepatology and Gastroenterology Unit of the First Department of Internal Medicine at the Aristotle University of Thessaloniki. He leads a lab and focuses on liver biology, liver immunology, HBV, HCV clinical liver diseases, HCC, etc.
Details of the Interview
1) Your recent article "Shedding light on the role of LAG-3 in hepatocellular carcinoma: unraveling immunomodulatory pathways" published in Hepatoma Research has garnered attention. Could you elaborate on the significance of your findings and their implications for the treatment of HCC?
2) What are some of the key challenges and opportunities in HCC research, and which areas do you believe warrant further investigation?
3) As a leader of a lab, could you tell us about what projects you are currently working on?
4) Can you recall a pivotal moment that inspired your career path in this field?
5) As a new Editorial Board member at Hepatoma Research, what are your expectations and suggestions for the development of the journal?
Editor: Eric Zhang
Language Editor: Catherine Yang
Production Editor: Yan Zhang
Respectfully Submitted by the Editorial Office of Hepatoma Research
